Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

FTSE 100 Focus: Haleon plc (LSE:HLN) Draws Fresh Investor Attention as consumer-health demand and brand strength

Haleon plc (LSE:HLN) is in focus across the FTSE 100 on 5 November 2026 as investors reassess the latest operating signals and the factors that could shapeEarningsbeyond the current session. The immediate debate centres on Sensodyne, Panadol, oral care, pricing and emerging-market growth. For …

Ankur Sharma | 06 November 2026

EKF Diagnostics Holdings plc (LSE:EKF) Buyback Keeps Ticking as Investors Bet on a Stronger Second Half

Discussion on investor forums andSocial Mediahas focused on the gap between management's confidence in a second-half pick-up and the cautious share price reaction. With the year-end approaching, the coming weeks will determine whether EKF can deliver the acceleration it has guided to.

Ankur Sharma | 06 November 2026

EDX Medical Group PLC (LSE:EDX) Workplace Health Screening Rollout Puts Cambridge Diagnostics Firm in the Spotlight

EDX moved its listing from the Aquis Stock Exchange to AIM in May 2026, increasing its visibility among UK investors. Since then, a steady flow of commercial updates, from workplace screening deals to NHS deployments of its rapid pneumonia test, has made LSE:EDX a …

Ankur Sharma | 06 November 2026

Hikma Pharmaceuticals Slips as Generics Pricing and Pipeline Progress Weighed

Founded in Jordan in 1978 by Samih Darwazah, Hikma has grown from a regional pharmaceutical company into a globally significant player in the generic and injectable pharmaceutical markets, with a particular strength in the US injectables segment where it holds a leading position in …

Divya Sood | 05 November 2026

Bioventix Plc (LSE:BVXP) Eases 3.70%: What Is Behind the Pullback?

Bioventix Plc — LSE:BVXP closed 3.70% lower on 05 November 2026, with the shares at 1,950p after a decrease of 75.00p on the day.

Ishan Mudgal | 05 November 2026

Diaceutics Plc (LSE:DXRX) Edges Lower 0.25%: What Is Driving the Decline?

Diaceutics Plc — LSE:DXRX closed 0.25% lower on 05 November 2026, with the shares at 202p after a decrease of 0.50p on the day.

Ishan Mudgal | 05 November 2026

Faron Pharmaceuticals Ltd (LSE:FARN) Rises 1.61%: What Is Supporting Investor Sentiment?

Faron Pharmaceuticals Ltd — LSE:FARN closed 1.61% higher on 05 November 2026, with the shares at 31.5p after an increase of 0.50p on the day.

Ishan Mudgal | 05 November 2026

Oxford BioDynamics Plc (OBD) in Focus: The Fresh Catalyst Investors Are Watching

• The stock is part of the FTSE AIM All-Share, whereLiquidityand company-specific catalysts can produce large daily moves.

Ankur Sharma | 05 November 2026

Why Proteome Sciences Plc (PRM) Is Suddenly in Focus on the FTSE AIM All-Share

• The stock is part of the FTSE AIM All-Share, whereLiquidityand company-specific catalysts can produce large daily moves.

Ankur Sharma | 05 November 2026

Why Physiomics Plc (PYC) Is Suddenly in Focus on the FTSE AIM All-Share

• The stock is part of the FTSE AIM All-Share, whereLiquidityand company-specific catalysts can produce large daily moves.

Ankur Sharma | 05 November 2026
Support

Hi! How can we help you today?

Loading…